Showing results (21-30 of 266) with videos related to
Sort By:
Pageof 27
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosisMaria Chiriaco, Giada Farinelli, Valentina Capo, et al.Immunology and Allergy Clinics of North America|May 25, 2010
Gene therapy for adenosine deaminase deficiencyBarbara Cappelli, Alessandro AiutiHuman Gene Therapy|August 30, 2017
Twenty-Five Years of Gene Therapy for ADA-SCID: From Bubble Babies to an Approved DrugFrancesca Ferrua, Alessandro AiutiHuman Gene Therapy|August 25, 2023
Realizing the Potential of Gene Therapies for Rare and Ultra-Rare Inherited DiseasesClaire Booth, Alessandro AiutiBlood Advances|June 27, 2019
In vivo dynamics of human hematopoietic stem cells: novel concepts and future directionsSerena Scala, Alessandro AiutiAIDS (London, England)|December 15, 2010
Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individualsAnna Kajaste-Rudnitski, Laura Galli, Silvia Nozza, et al.EMBO Molecular Medicine|July 2, 2017
Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cellsFrancesco Piras, Michela Riba, Carolina Petrillo, et al.Antimicrobial Agents and Chemotherapy|June 25, 2008
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharideDebora Pinna, Pasqua Oreste, Tiziana Coradin, et al.AIDS (London, England)|August 8, 2013
Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 diseaseSilvia Ghezzi, Laura Galli, Anna Kajaste-Rudnitski, et al.Journal of Virology|February 25, 2011
TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elementsAnna Kajaste-Rudnitski, Sara S Marelli, Cinzia Pultrone, et al.Pageof 27